Glabellar Rhytides

• CLINICAL_TRIALS research · 2024-09-19
  Clinical Trial Update: Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides [Phase 4]

  Phase 4 trial update comparing all botulinum toxin type A products for treating glabellar rhytides; the study is not yet recruiting.

• CLINICAL_TRIALS trial_result · 2017-06-23
  Clinical Trial Update: A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides [Phase 3]

  Phase 3 trial evaluating safety and efficacy of OnabotulinumtoxinA for forehead and glabellar rhytides has completed with results posted.

• CLINICAL_TRIALS trial_result · 2015-09-01
  Clinical Trial Update: Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines [Phase 4]

  Phase 4 trial evaluating botulinum toxin type A (BOTOX) for moderate to severe glabellar lines in Chinese patients; study completed with res…

• CLINICAL_TRIALS trial_result · 2011-09-12
  Clinical Trial Update: A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows [Phase 3]

  The document reports the completion of a Phase 3 long-term safety study of repeat PurTox treatments for glabellar rhytides.

• CLINICAL_TRIALS trial_result · 2011-09-12
  Clinical Trial Update: Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows [Phase 3]

  Phase 3 safety and efficacy study of PurTox Botulinum Toxin Type A for treating glabellar frown lines completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.